Tuesday, October 30, 2018

Dr Reddy#39;s gets 8 USFDA observations for Duvvada injectable site

Dr Reddy#39;s gets 8 USFDA observations for Duvvada injectable site The company#39;s Duvvada unit, known as FTO-VII, manufactures cytotoxic and hormonal injectables is under warning since November 2015, blocking any new approvals.

from Moneycontrol Business News https://ift.tt/2Q44aWo

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...